These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28072904)

  • 1. Resistance diagnosis and the changing economics of antibiotic discovery.
    McAdams D
    Ann N Y Acad Sci; 2017 Jan; 1388(1):18-25. PubMed ID: 28072904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Programs and Discoveries Aim to Combat Antibiotic Resistance.
    Hampton T
    JAMA; 2015 Jun 23-30; 313(24):2411-3. PubMed ID: 26039283
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance diagnosis and the changing epidemiology of antibiotic resistance.
    McAdams D
    Ann N Y Acad Sci; 2017 Jan; 1388(1):5-17. PubMed ID: 28134444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches are needed to develop tomorrow's antibacterial therapies.
    Spellberg B; Bartlett J; Wunderink R; Gilbert DN
    Am J Respir Crit Care Med; 2015 Jan; 191(2):135-40. PubMed ID: 25590154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of funding could undermine UK antibiotic resistance strategy, say experts.
    O'Dowd A
    BMJ; 2013 Dec; 347():f7618. PubMed ID: 24355390
    [No Abstract]   [Full Text] [Related]  

  • 6. A call for antibiotic alternatives research.
    Stanton TB
    Trends Microbiol; 2013 Mar; 21(3):111-3. PubMed ID: 23473628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Resistance: The Need For a Global Strategy.
    Elder DP; Kuentz M; Holm R
    J Pharm Sci; 2016 Aug; 105(8):2278-87. PubMed ID: 27397433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics: the changing regulatory and pharmaceutical industry paradigm.
    Bax R; Green S
    J Antimicrob Chemother; 2015 May; 70(5):1281-4. PubMed ID: 25634991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of antibiotic resistance: how much do we really know?
    Gandra S; Barter DM; Laxminarayan R
    Clin Microbiol Infect; 2014 Oct; 20(10):973-80. PubMed ID: 25273968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics in late clinical development.
    Fernandes P; Martens E
    Biochem Pharmacol; 2017 Jun; 133():152-163. PubMed ID: 27687641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing the benefits and costs of antibiotic drugs: the TREAT model.
    Leibovici L; Paul M; Andreassen S
    Clin Microbiol Infect; 2010 Dec; 16(12):1736-9. PubMed ID: 20673259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the current deadlock in antibiotic research.
    Schäberle TF; Hack IM
    Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial sensitivity--A natural resource to be protected by a Pigouvian tax?
    Vågsholm I; Höjgård S
    Prev Vet Med; 2010 Aug; 96(1-2):9-18. PubMed ID: 20570379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control.
    White AR;
    J Antimicrob Chemother; 2011 Sep; 66(9):1948-53. PubMed ID: 21700625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can antibiotic use be both just and sustainable... or only more or less so?
    Millar M
    J Med Ethics; 2011 Mar; 37(3):153-7. PubMed ID: 21059636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals.
    Kesselheim AS; Outterson K
    Health Aff (Millwood); 2010 Sep; 29(9):1689-96. PubMed ID: 20820028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, economic and societal impact of antibiotic resistance.
    Barriere SL
    Expert Opin Pharmacother; 2015 Feb; 16(2):151-3. PubMed ID: 25483564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance: who will pay the bills?
    Zaoutis TE
    Clin Infect Dis; 2009 Oct; 49(8):1185-6. PubMed ID: 19739974
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of new antibacterials: a laudable aim, but what is the value?
    Tillotson GS
    Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.